| Autor: |
Campiglio M; Institute of Physiology, Medical University Innsbruck, Innsbruck, Austria. marta.campiglio@i-med.ac.at., Dyrda A; Institute of Physiology, Medical University Innsbruck, Innsbruck, Austria., Tuinte WE; Institute of Physiology, Medical University Innsbruck, Innsbruck, Austria., Török E; Institute of Physiology, Medical University Innsbruck, Innsbruck, Austria. |
| Jazyk: |
angličtina |
| Zdroj: |
Handbook of experimental pharmacology [Handb Exp Pharmacol] 2023; Vol. 279, pp. 3-39. |
| DOI: |
10.1007/164_2022_627 |
| Abstrakt: |
In skeletal muscle, excitation-contraction (EC) coupling relies on the mechanical coupling between two ion channels: the L-type voltage-gated calcium channel (Ca V 1.1), located in the sarcolemma and functioning as the voltage sensor of EC coupling, and the ryanodine receptor 1 (RyR1), located on the sarcoplasmic reticulum serving as the calcium release channel. To this day, the molecular mechanism by which these two ion channels are linked remains elusive. However, recently, skeletal muscle EC coupling could be reconstituted in heterologous cells, revealing that only four proteins are essential for this process: Ca V 1.1, RyR1, and the cytosolic proteins Ca V β 1a and STAC3. Due to the crucial role of these proteins in skeletal muscle EC coupling, any mutation that affects any one of these proteins can have devastating consequences, resulting in congenital myopathies and other pathologies.Here, we summarize the current knowledge concerning these four essential proteins and discuss the pathophysiology of the Ca V 1.1, RyR1, and STAC3-related skeletal muscle diseases with an emphasis on the molecular mechanisms. Being part of the same signalosome, mutations in different proteins often result in congenital myopathies with similar symptoms or even in the same disease.
(© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.) |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
